← Back to Search

Cockroach Reduction Intervention for Childhood Asthma (ARCHS Trial)

N/A
Recruiting
Led By Felicia Rabito, PhD
Research Sponsored by Tulane University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 5 - 17 years with uncontrolled persistent asthma
Experiencing at least one of the following: one overnight hospitalization for asthma within the past six months OR two unscheduled clinic or emergency department visits for asthma within the last 12 months
Must not have
Cardiovascular disease that requires daily medication, excluding hypertension
Taking a beta-blocker
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3, 6, 9, 12 months
Awards & highlights

Summary

This trial is testing a cockroach reduction intervention to improve patient-centered asthma outcomes.

Who is the study for?
The ARCHS trial is for children aged 5-17 in the Greater New Orleans area with uncontrolled persistent asthma and exposure to cockroaches. They must have had recent hospital visits or symptoms due to asthma, sleep at the target home most of the week, and speak English or Spanish. Kids can't join if they smoke, take beta-blockers, have certain heart diseases (except hypertension), other serious illnesses requiring daily meds, are on immunotherapy, or plan to move soon.Check my eligibility
What is being tested?
This study tests two ways to reduce cockroach allergens in homes of asthmatic kids: one group uses insecticidal bait while another follows a tailored approach. The goal is to see which method better improves asthma-related health outcomes like symptom days, control over asthma, healthcare use and overall quality of life over a year.See study design
What are the potential side effects?
Since this trial involves environmental interventions rather than medications, direct side effects from treatments are minimal. However, there may be indirect effects related to changes in household pest populations.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 5 and 17 years old with asthma that isn't well-controlled.
Select...
I've been hospitalized overnight for asthma recently or had emergency visits twice last year.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I take daily medication for a heart condition, not including high blood pressure.
Select...
I am currently taking a beta-blocker medication.
Select...
I have a serious illness or chronic infection that needs daily medication.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3, 6, 9, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6, 9, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Level of Asthma control
Maximum number of symptom days in the previous two weeks
Number of participants with an asthma related hospitalization, unscheduled clinic or emergency room visit for asthma in the previous month
Secondary outcome measures
Asthma quality of life
Cockroach exposure

Trial Design

2Treatment groups
Active Control
Group I: Comparator 1 (tailored approach)Active Control1 Intervention
Multi-component intervention tailored to the participant's allergic profile.
Group II: Comparator 2 (insecticidal bait)Active Control1 Intervention
Insecticidal bait for cockroach reduction.

Find a Location

Who is running the clinical trial?

Patient-Centered Outcomes Research InstituteOTHER
563 Previous Clinical Trials
29,991,860 Total Patients Enrolled
Tulane UniversityLead Sponsor
118 Previous Clinical Trials
238,479 Total Patients Enrolled
Felicia Rabito, PhD4.146 ReviewsPrincipal Investigator - Tulane University School of Public Health and Tropical Medicine
Tulane University
5Patient Review
Dr. Rabito is truly impressive! His intelligence is unmatched, and he makes sure to spend quality time with each patient. Even if he runs late, he is always apologetic. I would gladly wait hours to see him again!

Media Library

Comparator 1 (tailored approach) Clinical Trial Eligibility Overview. Trial Name: NCT04331353 — N/A
Childhood Asthma Research Study Groups: Comparator 1 (tailored approach), Comparator 2 (insecticidal bait)
Childhood Asthma Clinical Trial 2023: Comparator 1 (tailored approach) Highlights & Side Effects. Trial Name: NCT04331353 — N/A
Comparator 1 (tailored approach) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04331353 — N/A
~49 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top